Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar;40(2):469-494.
doi: 10.1002/med.21519. Epub 2018 Jul 13.

Protein-protein interactions as antibiotic targets: A medicinal chemistry perspective

Affiliations
Review

Protein-protein interactions as antibiotic targets: A medicinal chemistry perspective

Peter J Cossar et al. Med Res Rev. 2020 Mar.

Abstract

There are 27 small molecule protein-protein interaction (PPI) modulators in Phase I, II, and III clinical trials targeting cancer, viruses, autoimmune disorders, and as immune suppression agents. Targeting PPIs as an antibiotic drug discovery strategy remains in relative infancy by comparison. However, a number of molecules are in development which target PPI within the replisome, divisome, transcriptome, and translatome are showing significant promise at the medicinal chemistry stage of drug development. Hence, the success of future PPI agents as antibiotics will build upon the techniques and design strategies of these molecules.

Keywords: antibacterial; antibiotic; protein-protein interaction (PPI).

PubMed Disclaimer

References

REFERENCES

    1. Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16:161-168.
    1. Shore CK, Coukell A. Roadmap for antibiotic discovery. Nat Microbiol. 2016;1:16083.
    1. Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013....
    1. Wright GD. Molecular mechanisms of antibiotic resistance. Chem Commun. 2011;47:4055.
    1. Mullard A. Preclinical antibiotic pipeline gets a pick-me-up. Nat Rev Drug Discov. 2017;16:741-742.

Publication types

Substances

LinkOut - more resources